Skip to main content
EDEN INNOVATIONS LTD logo

EDEN INNOVATIONS LTD — Investor Relations & Filings

Ticker · EDE ISIN · AU000000EDE1 ASX Manufacturing
Open in API
Filings indexed 1,439 across all filing types
Latest filing 2017-08-28 Share Issue/Capital Cha…
Country AU Australia
Listing ASX EDE

About EDEN INNOVATIONS LTD

https://edeninnovations.com/

Eden Innovations Ltd focuses on the development and commercialization of clean technologies, primarily specializing in carbon nanotube applications and hydrogen production. The company's flagship product, EdenCrete®, is a carbon nanotube-enriched concrete admixture designed to enhance the performance of concrete by improving tensile and flexural strength, increasing durability, and reducing shrinkage. This technology is utilized in large-scale infrastructure projects such as bridges, highways, and high-rise buildings. Additionally, the company offers OptiBlend®, a dual-fuel system that enables diesel engines to operate on a combination of natural gas and diesel, reducing fuel costs and emissions. Eden Innovations utilizes a proprietary pyrolysis process to produce hydrogen and high-quality carbon nanotubes from natural gas, facilitating carbon sequestration within industrial materials.

Recent filings

Filing Released Lang Actions
Issue and Lapse of ESOP Options 1 page 98.1KB
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from the Australian Securities Exchange dated 29 August 2017 regarding the issuance and lapse of ESOP (Employee Stock Option Plan) options. It details the number of options issued, their exercise price, expiration dates, vesting schedule, and options that have lapsed due to employee cessation. This is a clear update on share-based compensation and capital structure changes related to employee stock options. It is not a full financial report, audit, or earnings release, nor is it a regulatory certification or voting result. The content fits best under announcements related to share issues or capital changes, specifically about options granted and lapsed. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is short and focused on capital changes, not a report publication or regulatory filing. Confidence is high due to clear and specific content matching the SHA category.
2017-08-28 English
EdenCrete Approved for Use by Colorado DOT 2 pages 113.2KB
Regulatory Filings Classification · 95% confidence The document is an announcement from Eden Innovations Ltd regarding the approval of their product EdenCrete® by various Departments of Transportation (DOTs) in multiple US states. It details the product's approval status, field trials, and commercial use but does not contain financial statements, management discussion, or regulatory filings. The document is relatively short (3692 characters) and serves as a corporate announcement about product approvals and business developments rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a general regulatory announcement about business operations and approvals, which fits the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories.
2017-08-27 English
TAS: EdenCrete Approved for Use by Colorado DOT 3 pages 185.5KB
Regulatory Filings Classification · 95% confidence The document is an Australian Securities Exchange (ASX) announcement dated 28 August 2017 by Eden Innovations Ltd. It discusses the approval of EdenCrete® for use by the Colorado Department of Transportation and other US state DOTs. The content focuses on product approval, commercial use, and field trials, which are typical of a company announcement regarding product or business development. There is no indication of financial results, management changes, voting results, or regulatory filings. The document is not a report but an announcement of a business development event. Therefore, the most appropriate classification is a Regulatory Filing (RNS), as it is a general regulatory announcement that does not fit into more specific categories like earnings release or management information.
2017-08-27 English
Korean EdenCrete Trials Begin 3 pages 191.0KB
Regulatory Filings Classification · 90% confidence The document is an announcement on the Australian Securities Exchange dated 22 August 2017 regarding the commencement of trials of EdenCrete® in Korea. It discusses strategic development and market potential but does not contain financial statements, detailed financial results, or regulatory certifications. The document is relatively short (4667 characters) and serves as a corporate update or business development announcement rather than a formal financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is best classified as a general regulatory announcement about business activities, which fits the Regulatory Filings (RNS) category as a fallback for miscellaneous announcements that do not fit other specific categories.
2017-08-21 English
TAS: Korean EdenCrete Trials Begin 4 pages 211.1KB
Regulatory Filings Classification · 95% confidence The document is an Australian Securities Exchange (ASX) announcement dated 22 August 2017 by Eden Innovations Ltd. It discusses the commencement of trials for EdenCrete® in Korea, including background information on the company, the trials, and strategic development plans. The content is an announcement of a business development event rather than a financial report or detailed financial data. There are no financial statements, earnings data, or regulatory certifications present. The document is relatively short (5809 characters) and serves as a news release or update to shareholders and the market about a new trial and strategic partnership. This fits best under the category of a Regulatory Filing (RNS), which is the fallback for general regulatory announcements and miscellaneous filings that do not fit other specific categories.
2017-08-21 English
Appendix 3B 12 pages 159.7KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B' and is an announcement related to a new issue of securities, application for quotation of additional securities, and agreement. It contains detailed information about the class and number of securities issued, issue price, purpose of the issue, shareholder approvals, and calculation of placement capacity under ASX rules 7.1 and 7.1A. The document is a formal regulatory filing to the Australian Securities Exchange (ASX) concerning capital raising and securities issuance. It is not a financial report, earnings release, or management discussion, but rather a capital/financing update about new share issuance and related compliance information. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is a substantive filing, not just an announcement of a report or a certification.
2017-08-06 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.